Stopping aspirin when on a blood thinner lowers risk of bleeding, study finds

Talk to your doctor about whether taking aspirin can do you more harm than good.

11:01 AM

Author | Noah Fromson

Hand pouring aspirin pills into hand
Getty Images

If you're already taking one blood thinner, mounting research suggests you might not need to take a second one.

In fact, when patients who are on a commonly prescribed blood thinner stop taking aspirin, their risk of bleeding complications drops significantly, a Michigan Medicine study finds.

Researchers analyzed over 6,700 people treated at anticoagulation clinics across Michigan for venous thromboembolism, or blood clots, as well as atrial fibrillation, an irregular heart rhythm that can cause stroke. Patients were treated with the common blood thinner warfarin but also took aspirin despite not having history of heart disease.

MORE FROM THE LAB: Subscribe to our weekly newsletter

"We know that aspirin is not a panacea drug as it was once thought to be and can in fact lead to more bleeding events in some of these patients, so we worked with the clinics to reduce aspirin use among patients for whom it might not be necessary," said Geoffrey Barnes, M.D., senior author of the study and a cardiologist at the University of Michigan Health Frankel Cardiovascular Center.

Over the course of the study intervention, aspirin use among patients decreased by 46.6%. With aspirin used less commonly, the risk of a bleeding complication dropped by 32.3% — amounting to one major bleeding event prevented per every 1,000 patients who stop taking aspirin. Results are published in JAMA Network Open.

"When we started this study, there was already an effort by doctors to reduce aspirin use, and our findings show that accelerating that reduction prevents serious bleeding complications which, in turn, can be lifesaving for patients," said Barnes, who is also an associate professor of internal medicine at U-M Medical School and program director of the Michigan Anticoagulation Quality Improvement Initiative. "It's really important for physicians and health systems to be more cognizant about when patients on a blood thinner should and should not be using aspirin."

These findings show how important it is to only take aspirin under the direction of your doctor and not to start taking over-the-counter medicines like aspirin until you review with your care team if the expected benefit outweighs the risk.
Jordan Kendall Schaefer, MD

This de-escalation of aspirin use is based off several studies that found concerning links between concurrent use of aspirin and different blood thinners.

One study reported that patients taking warfarin and aspirin for atrial fibrillation and VTE experienced more major bleeding events and had more ER visits for bleeding than those taking warfarin alone. Similar results occurred for patients taking aspirin and direct oral anticoagulants – who were found more likely to have a bleeding event but not less likely to have a blood clot.

"While aspirin is an incredibly important medicine, it has a less widely used role than it did a decade ago," Barnes said. "But with each study, we are seeing that there are far fewer cases in which patients who are already on an anticoagulant are seeing benefit by adding aspirin on top of that treatment. The blood thinner they are taking is already providing some protection from clots forming."

For some people, aspirin can be lifesaving. Many patients who have a history of ischemic stroke, heart attack or a stent placed in the heart to improve blood flow – as well as those with a history of cardiovascular disease – benefit from the medication.

The challenge comes when some people take aspirin without a history of cardiovascular disease and are also prescribed an anticoagulant, said first author Jordan Schaefer, M.D., a hematologist at U-M Health and clinical associate professor of internal medicine at U-M Medical School.

"Many of these people were likely taking aspirin for primary prevention of heart attack or stroke, which we now know is less effective than once believed, and no one took them off of it when they started warfarin," Schaefer said. "These findings show how important it is to only take aspirin under the direction of your doctor and not to start taking over-the-counter medicines like aspirin until you review with your care team if the expected benefit outweighs the risk."

 

Live your healthiest life: Get tips from top experts weekly. Subscribe to the Michigan Health blog newsletter

Headlines from the frontlines: The power of scientific discovery harnessed and delivered to your inbox every week. Subscribe to the Michigan Health Lab blog newsletter

Like Podcasts? Add the Michigan Medicine News Break on Spotify, Apple Podcasts or anywhere you listen to podcasts.

Additional authors include Josh Errickson, Ph.D., Xiaokui Gu, M.D., M.A., Tina Alexandris-Souphis, R.N., Brian Haymart, R.N., M.S., Eva Kline-Rogers, M.S., R.N., N.P., Suman L. Sood, M.D., MSCE, James B. Froehlich, M.D., M.P.H., all of University of Michigan, Mona A. Ali, Pharm.D., Department of Heart and Vascular Services at Beaumont Hospital, Scott Katz, D.O., Division of Hospital Medicine at Henry Ford Hospital, Jay H. Kozlowski, M.D., Huron Valley Sinai Hospital, Gregory D. Krol, M.D.,Vinay Shah, M.D., both of Department of Internal Medicine at Henry Ford Hospital.

Support for the Michigan Anticoagulation Quality Improvement Initiative is provided by Blue Cross and Blue Shield of Michigan as part of the BCBSM Value Partnerships program.

During the study, Barnes reported receiving personal fees from Pfizer/Bristol Myers Squibb and Janssen, all of whom manufacture anticoagulants.

Like Podcasts? Add the Michigan Medicine News Break on iTunes or anywhere you listen to podcasts.

"Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation," JAMA Network Open. DOI: 10.1001/jamanetworkopen.2022.31973


More Articles About: Lab Report Vascular Disease Atrial fibrillation (Afib) Deep Vein Thrombosis (DVT) Heart disease Vascular Disease Prevention Heart Attack Risk Factors Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories two hearts next to each other with small figure people inside and out of it
Health Lab
How neutrophil calprotectin unmasks future atherosclerotic heart disease risk
The immune system is showing evidence of playing a roll in the emergence of atherosclerotic cardiovascular disease. A rush of neutrophils, or immune cells to the site could be an explanation for how this condition forms as well as how to prevent this heart disease in the future.
up close doctor in hospital with cardiology close up scans on monitors
Health Lab
Researchers find significant differences in care of life threatening shock after heart attack
A study finds most hospitals don’t see many cardiogenic shock patients. When they do, providers often do not have a standardized way of treating them.
blood vessel up close with red cells and yellow inside
Health Lab
Drug candidate successfully treats atherosclerosis, fatty liver disease in large mammals 
A compound that was previously found to treat severe fatty liver disease also reduces atherosclerosis, a primary driver of cardiovascular death, in non-human primates. The drug candidate was developed at the University of Michigan.
woman touching head talking to front desk person
Health Lab
Cognitive decline comes sooner for people with heart failure
There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study led by University of Michigan suggests. 
hands on book reading
Health Lab
Highly educated people face steeper mental declines after stroke
Stroke survivors who have attended some level of higher education may face even steeper mental declines, according to a study led by Michigan Medicine.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Epigenetics, Inflammation and the Human Immune System
People with diabetes often have a host of other conditions including cardiovascular disease and kidney disease driven by inflammation. On today's episode, we talk with Dr. Katherine Gallagher, professor of surgery, professor of microbiology and immunology, and the Leland Ira Doan Research Professor of Vascular Surgery at U of M, who is looking at how epigenetics - the influence of environmental factors and behaviors impact on gene expression - might explain changes in the immune system in people with cardiovascular disease, diabetes, and other conditions related to inflammation.